In an age of increasing digitisation, pharmaceutical product information is evolving. This transformation reflects growing recognition among regulators of the value of patient engagement and widespread societal calls for increased transparency of and access to medical information. We consider the future of pharmaceutical product information, reimagining the electronic product information (ePI) as an interoperable and informative platform that links core product information to a range of supporting medical information resources. We consider the benefits that this evolution can afford different stakeholder groups in terms of increased transparency, enriched information provision, and tailored information solutions, as well as the potential challenges that will need to be addressed. We also discuss the critical role that medical writers can play in informing and shaping the future of ePI for the benefit of all. Medical Writing. 2025;34(2):21–25. https://doi.org/10.56012/tcvr4151